Covid-19 disease is typified by respiratory symptoms. In severe cases respiratory failure occurs and must be carefully managed. Management can include supplementary oxygen therapy, non-invasive and invasive ventilation. In this article we describe the techniques shown to be effective in this patient group and highlight areas where future research is needed to guide the best.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020;323:1574-81.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 2020;324:782-93.
INTERIM GUIDANCE DOCUMENT. Available from: http://www. who.int/csr/disease/coronavirus_infections/en/index. [Last accessed on 2020 Oct 05].
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46:854-87.
Schjørring OL, Perner A, Wetterslev J, Lange T, Keus F, Laake JH, et al. Handling oxygenation targets in the intensive care unit (HOT-ICU) - Protocol for a randomised clinical trial comparing a lower vs a higher oxygenation target in adults with acute hypoxaemic respiratory failure. Acta Anaesthesiol Scand 2019;63:956-65.
Ricard JD, Roca O, Lemiale V, Corley A, Braunlich J, Jones P, et al. Use of nasal high flow oxygen during acute respiratory failure. Intensive Care Med 2020;46:2238-47.
Vianello A, Arcaro G, Molena B, Turato C, Sukthi A, Guarnieri G, et al. High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection. Thorax 2020;75:998-1000.
Guy T, Créac'hcadec A, Ricordel C, Salé A, Arnouat B, Bizec JL, et al. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur Respir J 2020;56:2001154; DOI: 10.1183/13993003.01154-2020.
Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: Low risk of bio-aerosol dispersion. Eur Respir J 2020;55:2000892; DOI: 10.1183/13993003.00892-2020.
Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med 2017;195:438-42.
Marini JJ, Gattinoni, L. Management of COVID-19 respiratory distress. JAMA 2020;323:2329-30.
Nightingale R, Nwosu N, Kutubudin F, Fletcher T, Lewis J, Frost F, et al. Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service. BMJ Open Respir Res 2020;7:e000639. doi:10.1136/bmjresp-2020-000639.
Couper K. ISRCTN-ISRCTN16912075: RECOVERY Respiratory Support: Respiratory Strategies in Patients with Coronavirus COVID-19 - CPAP, High-Flow Nasal Oxygen, and Standard Care. Available from: http://www.isrctn.com/ISRCTN16912075. [Last accessed 2020 Oct 05].
Tiss O. Several Dead as Iraq Hospital Treating Covid-19 Patients Runs Out of Oxygen. France 24; 2020. Available from: https://observers.france24. com/en/20200630-iraq-nassiriya-covid-19-hospital-patients-oxygen. [Last accessed 2020 Oct 05].
Winck JC, Ambrosino N. COVID-19 pandemic and noninvasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems. Pulmonology 2020;26:213-20.
Elharrar X, Trigui Y, Dols AM, Touchon F, Martinez S, Prud'homme E, et al. Use of prone positioning in nonintubated patients With COVID-19 and hypoxemic acute respiratory failure. JAMA 2020;323:2336-8.
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012;307:2526-33.
Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
Barnes T, Zochios V, Parhar K. Re-examining permissive hypercapnia in ARDS: A narrative review. Chest 2018;154:185-95.
Mireles-Cabodevila E, Dugar S, Chatburn RL. APRV for ARDS: The complexities of a mode and how it affects even the best trials. J Thorac Dis 2018;10:S1058-63.
Ho AT, Patolia S, Guervilly C. Neuromuscular blockade in acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials. J Intensive Care 2020;8:12.
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354:2564-75.
Centre, I. C. N. A. and R. ICNARC Report on COVID-19 in Critical Care: England, Wales and Northern Ireland. Available from: https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports. [Last accessed 2020 Oct 05].
Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368:2159-68.
NHS. Specialty Guides for Patient Management during the Coronavirus Pandemic; 2020. Available from: https://www.england.nhs.uk/coronavirus/secondary-care/other-resources/specialty-guides/#adult. [Last accessed on 2020 Oct 05].
Hong X, Xiong J, Feng Z, Shi Y. Extracorporeal membrane oxygenation (ECMO): Does it have a role in the treatment of severe COVID-19? Int J Infect Dis 2020;94:78-80.
Warren A, Camporota L, Vuylsteke A. Surge capacity and updated admission criteria: response of the NHS-commissioned national respiratory extracorporeal membrane oxygenation network to the COVID-19 pandemic. Br J Anaesth 2020;125:e282-3.
Mustafa AK, Alexander PJ, Joshi DJ, Tabachnick DR, Cross CA, Pappas PS, et al. Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure. JAMA Surg 2020;155:990-2.
Scott LK, Fccm M. COVID-19 Case report use of ECCO 2 R with the hemolung RAS in the treatment of severe hypercapnic respiratory failure caused by SARS-CoV-2 acute lung injury. Available from: https://www. alung.com/app/uploads/2020/05/Scott-User-Report-v2.1-13May2020. pdf. [Last accessed 2020 Oct 05].
McNamee JJ, Gillies MA, Barrett NA, Agus AM, Beale R, Bentley A, et al. pRotective vEntilation with veno-venouS lung assisT in respiratory failure: A protocol for a multicentre randomised controlled trial of extracorporeal carbon dioxide removal in patients with acute hypoxaemic respiratory failure. J Intensive Care Soc 2017;18:159-69.